The Main Stage on the show floor will host daily programming featuring thought leadership sessions, expert panels and the ...

In this Healio Video Perspective from Hawaiian Eye 2025, Erin Powers of Johnson & Johnson Surgical Vision discusses how the Tecnis Odyssey IOL has benefited ophthalmic practices.

In this Healio Video Perspective from Hawaiian Eye 2025, Jeffrey Whitman, MD, of Key-Whitman Eye Center, discusses the positive impact of the Tecnis Odyssey IOL on his practice.

Johnson & Johnson's Q4 2024 earnings missed EPS expectations, but broadly met revenue targets. Click here to read why JNJ ...

Below is Validea's guru fundamental report for JOHNSON & JOHNSON (JNJ). Of the 22 guru strategies we follow, JNJ rates highest using our Shareholder Yield Investor model based on the published ...

All participants will be in a listen-only mode until the question-and-answer session of the conference. This call is being ...

The MedTech segment provides solutions for heart disorders, stroke, orthopedics, surgeries, and vision care. Johnson & Johnson (NYSE:JNJ) ranks 4th on our list of the best dividend stocks.

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...